...
首页> 外文期刊>Current Protein & Peptide Science >Using Silico Methods Predicting Ligands for Orphan GPCRs
【24h】

Using Silico Methods Predicting Ligands for Orphan GPCRs

机译:使用Silico方法预测孤立GPCR的配体

获取原文
获取原文并翻译 | 示例

摘要

The G-protein coupled receptor (GPCR) superfamily is one of the most important drug target classes for the pharmaceutical industry. The completion of the human genome project has revealed that there are more than 300 potential GPCR targets of interest. The identification of their natural ligands can gain significant insights into regulatory mechanisms of cellular signaling networks and provide unprecedented opportunities for drug discovery. Much effort has been directed towards the GPCR ligand discovery study by both academic institutions and pharmaceutical industries. However, the endogenous ligands still remain unknown for about 150 GPCRs in the human genome. It is necessary to develop new strategies to predict candidate ligands for these so-called orphan receptors. Computational techniques are playing an increasingly important role in finding and validating novel ligands for orphan GPCRs (oGPCRs). In this paper, we focus on recent development in applying bioinformatics approaches for the discovery of GPCR ligands. In addition, some of the data resources for ligand identification are also provided.
机译:G蛋白偶联受体(GPCR)超家族是制药行业最重要的药物靶标类别之一。人类基因组计划的完成表明,有300多个潜在的GPCR感兴趣目标。鉴定其天然配体可以深入了解细胞信号网络的调控机制,并为药物发现提供前所未有的机会。学术机构和制药行业都已对GPCR配体发现研究进行了大量努力。但是,对于人类基因组中的约150个GPCR,内源性配体仍然未知。有必要开发新的策略来预测这些所谓的孤儿受体的候选配体。计算技术在寻找和验证孤儿GPCR(oGPCR)的新型配体中发挥着越来越重要的作用。在本文中,我们专注于应用生物信息学方法发现GPCR配体的最新进展。另外,还提供了一些用于配体鉴定的数据资源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号